Has Todd Dewey, MD received payments from drug or device companies?

Yes. Drug and device makers reported $128,024 in general payments to Todd Dewey, MD across 256 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Todd Dewey, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Todd Dewey, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Todd Dewey, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Dallas, TXNPI 1891783403

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (58.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Edwards Lifesciences accounts for 80.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2022 at $31,069 and has fallen 60.6% since, to $12,239 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$128,024in general payments, 2019–2025

Across 256 payments — averaging $500.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Edwards Lifesciences$103K
Medtronic$12K
Abbott$11K
Atricure, Inc.$1K
Kls-martin L.p.$336
Angiodynamics, Inc.$217
plus $354 from 6 others

$260,777in research payments, 2019–2025

Across 91 payments — averaging $2865.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Edwards Lifesciences$207K
Medtronic$16K
Boston Scientific$15K
Atricure, Inc.$12K
Quest Medical Inc.$11K

What the payments were for

Consulting fees$74,56358%
Speaking & faculty fees$9,9008%
Travel & lodging$33,20226%
Food & beverage$10,3598%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Edwards Lifesciences	131	$102,545
Medtronic(2 entities)	40	$12,210
Abbott	49	$11,279
Atricure, Inc.	11	$1,082
Kls-martin L.p.	14	$336
Angiodynamics, Inc.	1	$217
Abiomed	1	$136
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	1	$80
Biomerieux Inc	3	$45
Smith+Nephew	2	$32
Stryker	1	$31
Baxter Healthcare	2	$30

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Edwards SAPIEN 3 Transcatheter Heart Valve$60,398
Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$15,234
COREVALVE EVOLUT R$10,909
INSPIRIS RESILIA aortic valve$9,225
Epic Stented Tissue Valve$5,855
EDWARDS INTUITY Elite valve system$3,563
Epic$3,184
Mitra Clip system$593
SYNERGY ABLATION SYSTEM$521
SAPIEN 3 Ultra RESILIA$347
CoreValve Evolut$257
Auryon Laser System 100-120 Vac$217
ATRICLIP LAA EXCLUSION SYSTEM$153
Impella$136
Bioprosthetic Mitral Valve$131
EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$115

How this compares

$128,024 in reported general payments places this provider in the 95th percentile of 424 thoracic surgery (cardiothoracic vascular surgery) providers in Texas.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Texas →

Medicare billing

Part B allowed, 2024

$167,309

Medicare patients

179

Services billed

341

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in Dallas

Robert HebelerDallas$723K
Michael WaitDallas$187K
Juan MachannafordDallas$164K
Aldo Rafael-YarihuamanDallas$142K
Gary SchwartzDallas$77K
Jaye WestonDallas$70K
Brandon HillDallas$53K
Ryan DaviesDallas$51K
Dan MeyerDallas$47K
Eitan Podgaetz GliksbergDallas$45K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →